Furthermore, we analyzed the triple correlation of NR4A1/c-Fos/PRDX6 and found that simultaneous low expression of NR4A1 and high expression of c-Fos and PRDX6 were associated with shorter overall survival in patients with BC (Fig. 8e). This evidence concerns the gene FOS and breast cancer.